fiercepharma.com
fiercepharma.com
Tweets from the Fierce Life Sciences editorial teamSource
West End, District of Columbia
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
2 reviews

RECENT ARTICLES

Sort by:
No Rating
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo's licensing deal

Former AstraZeneca exec charged with insider trading in Daiichi Sankyo's licensing deal

Buying 500 shares of Daiichi Sankyo stock 16 days before the company signed a lucrative licensing deal with AstraZeneca has a former AZ executive in the Securities and Exchange Commission's (SEC's) crosshairs. According to an SEC complaint, Hugues Joublin, Ph.D.—who was AZ’s global head of corporate affairs for oncology—has been charged with taking advantage of his advance knowledge of the 2019 deal to buy $20,000 worth of stock. Joublin became aware of AZ’s impending deal to acquire commercial rights to Daiichi Sankyo’s breast cancer drug Enhertu on March 6, 2019, the filing alleges; six...

May 31
Share
Save
Review
No Rating
Bayer donates millions of tablets of chloroquine to help in COVID-19 fight

Bayer donates millions of tablets of chloroquine to help in COVID-19 fight

Biopharma companies have scrambled to start new R&D projects and repurpose existing medicines amid the COVID-19 crisis. Now, Bayer is donating an older treatment to the U.S. government for potential use.The company is donating 3 million tablets of malaria medicine chloroquine, a decades-old drug that's available for cheap. Axios first news of the donation Wednesday, citing a senior HHS official and another source with knowledge of the plan.Bayer confirmed the donation Thursday.We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more...

March 18, 2020
Share
Save
Review
  • Total 2 items
  • 1
AUTHORS
Kevin Dunleavy

Kevin Dunleavy

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A